HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 19.28
Day range
zł 19.28 - zł 21.90
Year range
zł 17.62 - zł 57.30
Market cap
502.86M PLN
Avg Volume
56.96K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 28.49M | 60.89% |
Operating expense | 63.99M | 72.67% |
Net income | -35.05M | -26.30% |
Net profit margin | -123.04 | 21.50% |
Earnings per share | — | — |
EBITDA | -39.12M | -73.04% |
Effective tax rate | -0.45% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 225.93M | -3.31% |
Total assets | 378.78M | -6.06% |
Total liabilities | 234.89M | 63.56% |
Total equity | 143.88M | — |
Shares outstanding | 23.12M | — |
Price to book | 3.10 | — |
Return on assets | -26.45% | — |
Return on capital | -40.30% | — |
Cash Flow
Net change in cash
| (PLN) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -35.05M | -26.30% |
Cash from operations | -27.94M | -43.38% |
Cash from investing | 9.14M | 331.88% |
Cash from financing | 2.16M | 689.92% |
Net change in cash | -16.39M | 24.51% |
Free cash flow | 245.89M | 3,028.15% |
About
Founded
2007
Website
Employees
328
